Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene

View through CrossRef
AbstractHemophilia is a genetic disease caused by a deficiency of blood coagulation factor VIII or IX. Bleeding into joints is the most frequent manifestation of hemophilia. Hemarthrosis results in an inflammatory and proliferative disorder termed hemophilic synovitis (HS). In time, a debilitating, crippling arthritis, hemophilic arthropathy, develops. Although the clinical sequence of events from joint bleeding to synovitis to arthropathy is well documented, the component or components in blood and the molecular changes responsible for hemophilic synovitis are not known. Iron has long been suspected to be the culprit but direct evidence has been lacking. Previously, we showed that iron increased human synovial cell proliferation and induced c-myc expression. Here we show that bleeding into a joint in vivo and iron in vitro result in increased expression of the p53-binding protein, mdm2. Iron induced the expression of mdm2 by normal human synovial cells approximately 8-fold. In a murine model of human hemophilia A, hemarthrosis resulted in pathologic changes observed in human hemophilic synovitis and a marked increase in synovial cell proliferation. Iron, in vitro, induced the expression of mdm2. The molecular changes induced by iron in the blood may be the basis of the increase in cell proliferation and the development of hemophilic synovitis. (Blood. 2004;104:2060-2064)
Title: Pathobiology of hemophilic synovitis I: overexpression of mdm2 oncogene
Description:
AbstractHemophilia is a genetic disease caused by a deficiency of blood coagulation factor VIII or IX.
Bleeding into joints is the most frequent manifestation of hemophilia.
Hemarthrosis results in an inflammatory and proliferative disorder termed hemophilic synovitis (HS).
In time, a debilitating, crippling arthritis, hemophilic arthropathy, develops.
Although the clinical sequence of events from joint bleeding to synovitis to arthropathy is well documented, the component or components in blood and the molecular changes responsible for hemophilic synovitis are not known.
Iron has long been suspected to be the culprit but direct evidence has been lacking.
Previously, we showed that iron increased human synovial cell proliferation and induced c-myc expression.
Here we show that bleeding into a joint in vivo and iron in vitro result in increased expression of the p53-binding protein, mdm2.
Iron induced the expression of mdm2 by normal human synovial cells approximately 8-fold.
In a murine model of human hemophilia A, hemarthrosis resulted in pathologic changes observed in human hemophilic synovitis and a marked increase in synovial cell proliferation.
Iron, in vitro, induced the expression of mdm2.
The molecular changes induced by iron in the blood may be the basis of the increase in cell proliferation and the development of hemophilic synovitis.
(Blood.
2004;104:2060-2064).

Related Results

A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic Arthropathy
A Translational Study of TNF-Alpha Antagonists as an Adjunctive Therapy for Preventing Hemophilic Arthropathy
Repeated intra-articular hemorrhages lead to hemophilic arthropathy in severe hemophilia. Inflammation and pro-inflammatory cytokines (e.g., tumor necrosis factor alpha (TNFα)) mig...
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
<div>Abstract<p>Overexpression of MDM2 has been related to oncogenesis. In this communication, we present evidence to show that MDM2 controls the cell cycle–dependent e...
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
Data from MDM2 Controls the Timely Expression of Cyclin A to Regulate the Cell Cycle
<div>Abstract<p>Overexpression of MDM2 has been related to oncogenesis. In this communication, we present evidence to show that MDM2 controls the cell cycle–dependent e...
Abstract 1768: The oncogene Mdmx promotes genomic instability independent of p53.
Abstract 1768: The oncogene Mdmx promotes genomic instability independent of p53.
Abstract Mdmx is upregulated in many human cancers. As a member of the Mdm2 protein family, Mdmx functions similar to Mdm2 as a negative regulator of the tumor suppr...
Abstract 1792: MDM2 promoter variants and mRNA expression in irradiated lymphocytes.
Abstract 1792: MDM2 promoter variants and mRNA expression in irradiated lymphocytes.
Abstract Background. The ubiquitin ligase protein MDM2 plays an important role in cellular processes like growth arrest, senescence and apoptosis, and one of its mai...
MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis
MDM2 SNP309, gene-gene interaction, and tumor susceptibility: an updated meta-analysis
Abstract Background The tumor suppressor gene p53 is involved in multiple cellular pathways including apoptosis, transcriptional control, and cel...
Abstract 1645: Discovery of AMG 232, an inhibitor of the MDM2-p53 interaction: From lead to a clinical candidate
Abstract 1645: Discovery of AMG 232, an inhibitor of the MDM2-p53 interaction: From lead to a clinical candidate
Abstract The p53 tumor suppressor is controlled by MDM2, which binds p53 and negatively regulates its transcriptional activity and stability. Many tumors overproduce...

Back to Top